FreeS Fund Earns Ten Honors from Zero2IPO, PEDaily, ChinaVenture & GEW, CVCRI, ChinaRong360, Wanbang RB, and Lancha Consumer | FreeS Matters
Continuously hiring investors
峰瑞资本
@freesfund
512 articles
Articles
Expansion or Store Closures: Reassessing Offline Opportunities | Li Feng Column
From "Store Opening Boom" to "Store Closing Wave": Reassessing Offline Opportunities
Live at 10 AM Tomorrow | New Opportunities in the Changing Landscape of Drug R&D
See you tomorrow at 10 a.m. sharp.
How Should We Think About the Present and Future of Drug R&D? | FreeS Fund Dialogue Vol. 2 — Final 2 Days to Register
What new variables and opportunities are emerging in the drug development industry?
FreeS Fund Report 25: Food Investment Through the Lens of China's Dietary Structure
What will we eat in the future?
New Opportunities Amid the Great Transformation in Drug R&D | FreeS Fund Dialogue Session 2 Now Open for Registration
Breakthroughs and Acceleration in New Drug R&D
A Conversation with Zhang Liaoyuan: Two Years After IPO, How Is Three Squirrels Thinking About What's Next? | FreeS Fund Interview
What is Zhang Liaoyao's ultimate battleground for brands?
Going live tonight at 8:30 PM | A conversation on opportunities and trends in the brain science industry
See you at 8:30 tonight.
FreeS Report 24 | Embracing the "Smartest" Opportunity: Investing Boldly in Brain and Neuroscience
If the universe is complex, mysterious, and captivating, so is the brain.
Can Hot Noodles + Hot Capital Cook Up a Chinese "McDonald's"? | FreeS Fund Daily Business Musings
What's Behind the High Valuations in Food and Beverage? Making Sense of the Chinese Restaurant Chain Opportunity